In summary, the possible antidepressant effect of metformin supports the involvement of inflammation and oxidative stress in depression via diverse signaling molecules and pathways including Nrf2, pro-inflammatory cytokines and the AMPK/BDNF and NFκB pathways. Here, BDNF is linked to depressive disorder.